University of Saskatchewan
Saskatoon, Saskatchewan, S7N0W8, Canada
NCT Number: NCT01642745
The study will compare the airway responses to two bronchoconstricting agents, mannitol and methacholine.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Saskatoon, Saskatchewan, S7N0W8, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
two minutes of aerosol inhalation of concentrations of methacholine ranging from 0.03 - 256mg/mL
single deep inhalation of dry powder per dose doses range from 0mg - 160mg (cumulative dose range 0mg-635mg).
Time frame: Visit 1 (Day 1)
The two minute tidal breathing PC20 with be captured once at visit 1.
Time frame: Visit 2 = up to 13 days
The PD15 to mannitol will be captured once at either visit 2 or visit 3.
Time frame: Visit 3 = up to 14 days
The PC20 to methacholine (deep inhalation) will be captured once at either visit 2 or visit 3.
University of Saskatchewan
Other
Mannitol and Methacholine Responsiveness: Effects of Deep Inhalations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394127
Asthma, Asthma Chronic
Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT03937804
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial Details